Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR0714)
Drug Name
Fluocinonide
Synonyms
Fluocinolide; Fluocinolide acetate; Fluocinolone acetonide 21-acetate; Fluocinolone acetonide acetate; Fluocinonide Emulsified Base; Fluocinonide [USAN:BAN:INN:JAN]; Fluocinonide(Vanos); Fluocinonide, micronised; Fluocinonido; Fluocinonido [INN-Spanish]; Fluocinonidum; Fluocinonidum [INN-Latin]; Fluonex; Fluzon; LIDEX-E; Lidex E; Lonide; Bestasone; Biscosal; Cortalar; Lyderm; Metosyn; Straderm; Synalar acetate; Topsymin; Topsyn; fluocinonide; 2W4A77YPAN; 356-12-7; C26H32F2O7; EINECS 206-597-6; Lidex; NSC 101791; UNII-2W4A77YPAN; Vanos
Indication Atopic dermatitis [ICD11: EA80] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 494.5 Topological Polar Surface Area 99.1
Heavy Atom Count 35 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 9
Cross-matching ID
PubChem CID
9642
PubChem SID
9220 ; 855724 ; 7847391 ; 7979242 ; 8156926 ; 10321975 ; 11466802 ; 11467922 ; 11486523 ; 12173604 ; 14835368 ; 14933065 ; 25654074 ; 29228218 ; 46504523 ; 47276849 ; 47500781 ; 47945071 ; 48395149 ; 49698636 ; 50019429 ; 50104032 ; 57325738 ; 78820947 ; 85787530 ; 92125814 ; 92717057 ; 99368359 ; 103556997 ; 103914444 ; 104170119 ; 104321094 ; 121362590 ; 121363485 ; 124758677 ; 124800848 ; 126628971 ; 126654105 ; 127307277 ; 134224335 ; 134337717 ; 134973110 ; 135692551 ; 135984719 ; 137005250 ; 139999927 ; 144115989 ; 144203989 ; 152035935 ; 152344176
ChEBI ID
CHEBI:5109
CAS Number
356-12-7
TTD Drug ID
D03ZZK
Formula
C26H32F2O7
Canonical SMILES
CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
InChI
1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1
InChIKey
WJOHZNCJWYWUJD-IUGZLZTKSA-N
The Predicted Metabolic Roadmap of This Drug
The Full List of Predicted Drug Metabolites (PDM) of This Drug
PDM Name PDM ID PubChem ID Reaction PDM Level Biosystem
Amcinonide M1 PDM007077
21980959
Hydrolysis - Hydrolysis of carboxylic acid ester 1 Human
Fluocinonide M2 PDM007183
3381
Hydrolysis - Hydrolysis of carboxylic acid ester 1 Human
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[2]
References
1 Fluocinonide was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. Drug Metab Dispos. 2013 Feb;41(2):379-89.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.